Lifestyle changes for obese men with sexual dysfunction and tinnitus

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enroll forty obese males suffering from subjective tinnitus and erectile dysfunction. Participants will be divided into two groups, with both groups following a low-calorie diet for 12 weeks. Group I will also engage in supervised aerobic walking training for 45 minutes, three times a week, over the same period. The goal is to assess the impact of these lifestyle changes on their conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* obese person
* body mass index less than 40 kg/m2 and more than 30 kg/m2
* males with subjective tinnitus (bilateral presentation from at least 24 weeks).
* males with sexual dysfunction (erectile dysfunction from at least 24 weeks)

Exclusion Criteria:

* cardiac diseased males
* respiratory diseased males
* hepatic, musculoskeletal, and hepatic diseased males
* diabetic males

Where it's running

• faculty of physical therapy Cairo university
  Dokki, Giza Governorate, Egypt Recruiting

Study contacts

• Principal investigator: Ali Ismail, lecturer — Cairo University
• Study coordinator: Ali Isamil, Lecturer
• Email: ali.mohamed@pt.cu.edu.eg
• Phone: 0201005154209

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists

  This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.

  Recruiting at 9 sites Phase 1 Amgen · Phoenix, Arizona and 8 other locations · NCT07908316

• HIP2602 for Erectile Dysfunction: Testing a new treatment in adults

  This study tests whether HIP2602, alone or with related formulations, can improve erectile function in adult men with long-standing erectile dysfunction who partner with the same adult female partner.

  Recruiting Phase 3 Hanmi Pharmaceutical Company Limited · Busan · NCT07899073

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.